Cargando…
Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria
OBJECTIVES: This study aimed to assess the safety and effectiveness of self-managed misoprostol abortions obtained outside of the formal health system in Lagos State, Nigeria. DESIGN: This was a prospective cohort study among women using misoprostol-containing medications purchased from drug sellers...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223139/ https://www.ncbi.nlm.nih.gov/pubmed/32376752 http://dx.doi.org/10.1136/bmjopen-2019-034670 |
_version_ | 1783533703962558464 |
---|---|
author | Stillman, Melissa Owolabi, Onikepe Fatusi, Adesegun O Akinyemi, Akanni I Berry, Amanda L Erinfolami, Temitope P Olagunju, Olalekan S Väisänen, Heini Bankole, Akinrinola |
author_facet | Stillman, Melissa Owolabi, Onikepe Fatusi, Adesegun O Akinyemi, Akanni I Berry, Amanda L Erinfolami, Temitope P Olagunju, Olalekan S Väisänen, Heini Bankole, Akinrinola |
author_sort | Stillman, Melissa |
collection | PubMed |
description | OBJECTIVES: This study aimed to assess the safety and effectiveness of self-managed misoprostol abortions obtained outside of the formal health system in Lagos State, Nigeria. DESIGN: This was a prospective cohort study among women using misoprostol-containing medications purchased from drug sellers. Three telephone-administered surveys were conducted over 1 month. SETTING: Data were collected in 2018 in six local government areas in Lagos State. PARTICIPANTS: Drug sellers attempted to recruit all women who purchased misoprostol-containing medication. To remain in the study, participants had to be female and aged 18–49, and had to have purchased the medication for the purpose of abortion. Of 501 women initially recruited, 446 were eligible for the full study, and 394 completed all three surveys. PRIMARY AND SECONDARY OUTCOME MEASURES: Using self-reported measures, we assessed the quality of information provided by drug sellers; the prevalence of potential complications; and the proportion with completed abortions. RESULTS: Although drug sellers provided inadequate information about the pills, 94% of the sample reported a complete abortion without surgical intervention about 1 month after taking the medication. Assuming a conservative scenario where all individuals lost to follow-up had failed terminations, the completion rate dropped to 87%. While 86 women reported physical symptoms suggestive of complications, only six of them reported wanting or needing health facility care and four subsequently obtained care. CONCLUSIONS: Drug sellers are an important source of medical abortion in this setting. Despite the limitations of self-report, many women appear to have effectively self-administered misoprostol. Additional research is needed to expand the evidence on the safety and effectiveness of self-use of misoprostol for abortion in restrictive settings, and to inform approaches that support the health and well-being of people who use this method of abortion. |
format | Online Article Text |
id | pubmed-7223139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-72231392020-05-15 Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria Stillman, Melissa Owolabi, Onikepe Fatusi, Adesegun O Akinyemi, Akanni I Berry, Amanda L Erinfolami, Temitope P Olagunju, Olalekan S Väisänen, Heini Bankole, Akinrinola BMJ Open Global Health OBJECTIVES: This study aimed to assess the safety and effectiveness of self-managed misoprostol abortions obtained outside of the formal health system in Lagos State, Nigeria. DESIGN: This was a prospective cohort study among women using misoprostol-containing medications purchased from drug sellers. Three telephone-administered surveys were conducted over 1 month. SETTING: Data were collected in 2018 in six local government areas in Lagos State. PARTICIPANTS: Drug sellers attempted to recruit all women who purchased misoprostol-containing medication. To remain in the study, participants had to be female and aged 18–49, and had to have purchased the medication for the purpose of abortion. Of 501 women initially recruited, 446 were eligible for the full study, and 394 completed all three surveys. PRIMARY AND SECONDARY OUTCOME MEASURES: Using self-reported measures, we assessed the quality of information provided by drug sellers; the prevalence of potential complications; and the proportion with completed abortions. RESULTS: Although drug sellers provided inadequate information about the pills, 94% of the sample reported a complete abortion without surgical intervention about 1 month after taking the medication. Assuming a conservative scenario where all individuals lost to follow-up had failed terminations, the completion rate dropped to 87%. While 86 women reported physical symptoms suggestive of complications, only six of them reported wanting or needing health facility care and four subsequently obtained care. CONCLUSIONS: Drug sellers are an important source of medical abortion in this setting. Despite the limitations of self-report, many women appear to have effectively self-administered misoprostol. Additional research is needed to expand the evidence on the safety and effectiveness of self-use of misoprostol for abortion in restrictive settings, and to inform approaches that support the health and well-being of people who use this method of abortion. BMJ Publishing Group 2020-05-05 /pmc/articles/PMC7223139/ /pubmed/32376752 http://dx.doi.org/10.1136/bmjopen-2019-034670 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Global Health Stillman, Melissa Owolabi, Onikepe Fatusi, Adesegun O Akinyemi, Akanni I Berry, Amanda L Erinfolami, Temitope P Olagunju, Olalekan S Väisänen, Heini Bankole, Akinrinola Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria |
title | Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria |
title_full | Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria |
title_fullStr | Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria |
title_full_unstemmed | Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria |
title_short | Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria |
title_sort | women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in lagos state, nigeria |
topic | Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223139/ https://www.ncbi.nlm.nih.gov/pubmed/32376752 http://dx.doi.org/10.1136/bmjopen-2019-034670 |
work_keys_str_mv | AT stillmanmelissa womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria AT owolabionikepe womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria AT fatusiadeseguno womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria AT akinyemiakannii womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria AT berryamandal womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria AT erinfolamitemitopep womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria AT olagunjuolalekans womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria AT vaisanenheini womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria AT bankoleakinrinola womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria |